Journal of Molecular Medicine-Jmm

Papers
(The H4-Index of Journal of Molecular Medicine-Jmm is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches107
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies57
AMPK: a key regulator of energy stress and calcium-induced autophagy56
Obesity and its impact on COVID-1955
Glycosylation is a key in SARS-CoV-2 infection55
Disturbed lipid and amino acid metabolisms in COVID-19 patients53
The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis52
Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions51
Organoids of the female reproductive tract49
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases44
Extracellular vesicles-associated tRNA-derived fragments (tRFs): biogenesis, biological functions, and their role as potential biomarkers in human diseases43
Evolving AAV-delivered therapeutics towards ultimate cures43
Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell42
Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional role41
Genetic engineering in organoids37
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis37
The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection36
High glucose: an emerging association between diabetes mellitus and cancer progression36
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota33
Memantine in neurological disorders – schizophrenia and depression32
NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα(12/13)/MAPK signaling pathway31
High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity31
Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders31
Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease29
Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer29
Multiple sclerosis is linked to MAPKERK overactivity in microglia27
Clinical perspectives on the age-related increase of immunosuppressive activity27
0.05203104019165